AstraZeneca (AZN) is up 101.5%, or $94.16 to $186.93.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AZN:
- AstraZeneca’s AZD4063 Edges Forward in Rare Genetic Cardiomyopathy Trial: What Investors Should Watch
- AstraZeneca Completes Key Drug–Interaction Study for AZD5004, Nudging Pipeline Risk Lower
- AstraZeneca rises 104.9%
- AstraZeneca reports FDA issued CRL for BLA for subcutaneous Saphnelo
- AstraZeneca, Daiichi Sankyo announce Datroway sBLA granted priority review